Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Dec 30;43(4):281-9.
eCollection 2012 Oct.

Cancer incidence and mortality in Manizales 2003-2007

Guillermo López Guarnizo  1 , Nelson Arias Ortiz  2 , Walter Arboleda Ruiz  3
Affiliations

Cancer incidence and mortality in Manizales 2003-2007

Guillermo López Guarnizo et al. Colomb Med (Cali). .

Abstract
in English, Spanish

Objective: To describe cancer incidence and mortality in Manizales during the 2003-2007 period from population-based information.

Methods: The information was obtained from the Manizales Cancer Registry and DANE. We analyzed new cases and cancer deaths of individuals residing in Manizales from 1 January 2003 to 31 December 2007. Cases reported correspond to primary invasive malignant tumors, in all locations, except basal cell carcinoma of the skin. We checked the internal consistency of the data and applied quality indicators suggested by the IARC. The population at risk was obtained from population projections (1985 -- 2020, DANE). Specific rates were estimated by gender and age (18 quinquennial groups), and standardized to the world population directly referenced.

Results: There were 3416 new cases and 1895 deaths from cancer. The age- standardized incidence rate (ASR) per 100,000 people-years for all primary locations (except skin) was 162.4 in women and 166.2 in men. Cancer accounted for 19.8% of mortality in Manizales with ASR per 100,000 people-years of 92.1 in men and 83.6 in women.

Conclusions: The risk of developing cancer or dying from cancer in Manizales is intermediate and similar to national estimates. The information generated by the PCR-M meets international quality standards, so it is necessary to ensure sustainability and improvement.

Objetivo: Describir la incidencia y mortalidad por cáncer en Manizales en el quinquenio 2003- 2007 a partir de información de base poblacional.

Metodos: La información fue obtenida del Registro poblacional de cáncer de Manizales y del DANE. Se analizaron los casos nuevos y las muertes por cáncer ocurridas en personas residentes en Manizales entre el 1º de enero de 2003 y el 31º de diciembre de 2007. Los casos registrados corresponden a tumores malignos invasivos primarios, en todas las localizaciones, incluidos carcinomas escamocelulares de piel y se excluyeron carcinomas basocelulares de la piel, aunque los escamocelulares no se tienen en cuenta en los análisis por su baja mortalidad. Se verificó la consistencia interna de los datos y se aplicaron indicadores de calidad sugeridos por la IARC. La población en riesgo se obtuvo de las proyecciones de población 1985-2020 del DANE. Se estimaron tasas específicas por sexo y edad (18 grupos quinquenales), y se estandarizaron directamente con la población mundial de referencia.

Resultados: Se registraron 3.416 casos nuevos y 1.895 muertes por cáncer. La Tasa de Incidencia Ajustada por Edad (TIAE) por 100.000 personas-año para todas las localizaciones primarias (excepto piel) fue de 162,4 en mujeres y 166,2 en hombres. El cáncer representó el 19,8% de la mortalidad en Manizales con TMAE por 100.000 personas-año de 92,1 en hombres y 83,6 en mujeres.

Conclusiones: El riesgo de desarrollar cáncer o morir por esta causa en Manizales es intermedio y similar a las estimaciones nacionales. El RPCa-M cumple con los estándares internacionales de calidad, es decir, es preciso garantizar su sostenibilidad y mejoramiento.

Keywords: Neoplasm; incidence; mortality; population registries; population surveillance.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: The authors declare having no conflict of interest in the creation of this document.

Figures

Figure 1
Figure 1. Population structure by age and gender. Manizales, 2005
Figure 2
Figure 2. Incidence and mortality due to cancer - First locations by gender (AAR per 100,000 people-year). Manizales, 2003-2007
Figure 3
Figure 3. Specific incidence rates by age in women and men, first 5 locations. (Rates per 100,000 p-y). Manizales, 2003-2007
See this image and copyright information in PMC

Similar articles

  • Trends in cancer incidence and mortality in Manizales, Colombia, 2008-2017.
    Arias-Ortiz N, Rodríguez-Betancourt JD. Arias-Ortiz N, et al. Colomb Med (Cali). 2022 Mar 30;53(1):e2044920. doi: 10.25100/cm.v53i1.4920. eCollection 2022 Jan-Mar. Colomb Med (Cali). 2022. PMID: 36415595 Free PMC article.
  • Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    AIRTUM Working Group; Busco S, Buzzoni C, Mallone S, Trama A, Castaing M, Bella F, Amodio R, Bizzoco S, Cassetti T, Cirilli C, Cusimano R, De Angelis R, Fusco M, Gatta G, Gennaro V, Giacomin A, Giorgi Rossi P, Mangone L, Mannino S, Rossi S, Pierannunzio D, Tavilla A, Tognazzo S, Tumino R, Vicentini M, Vitale MF, Crocetti E, Dal Maso L. AIRTUM Working Group, et al. Epidemiol Prev. 2016 Jan-Feb;40(1 Suppl 2):1-120. doi: 10.19191/EP16.1S2.P001.035. Epidemiol Prev. 2016. PMID: 26951748
  • [Liver cancer epidemiology in China, 2015].
    An L, Zeng HM, Zheng RS, Zhang SW, Sun KX, Zou XN, Chen R, Wang SM, Gu XY, Wei WW, He J. An L, et al. Zhonghua Zhong Liu Za Zhi. 2019 Oct 23;41(10):721-727. doi: 10.3760/cma.j.issn.0253-3766.2019.10.001. Zhonghua Zhong Liu Za Zhi. 2019. PMID: 31648492 Chinese.
  • [SENTIERI - Epidemiological Study of Residents in National Priority Contaminated Sites. Sixth Report].
    Zona A, Fazzo L, Benedetti M, Bruno C, Vecchi S, Pasetto R, Minichilli F, De Santis M, Nannavecchia AM, Di Fonzo D, Contiero P, Ricci P, Bisceglia L, Manno V, Minelli G, Santoro M, Gorini F, Ancona C, Scondotto S, Soggiu ME, Scaini F, Beccaloni E, Marsili D, Villa MF, Maifredi G, Magoni M, Iavarone I; Gruppo di lavoro SENTIERI 2019-2022. Zona A, et al. Epidemiol Prev. 2023 Jan-Apr;47(1-2 Suppl 1):1-286. doi: 10.19191/EP23.1-2-S1.003. Epidemiol Prev. 2023. PMID: 36825373 Italian.
  • Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K, Williams J, Qi YP, Gutman J, Yeung L, Mai C, Finkelstain J, Mehta S, Pons-Duran C, Menéndez C, Moraleda C, Rogers L, Daniels K, Green P. Crider K, et al. Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
See all similar articles

Cited by

See all "Cited by" articles

References

    1. P Kanavos. The rising burden of cancer in the developing world. Ann Oncol. 2006;17(8):15–23. - PubMed
    1. Pisani P. The cancer burden and cancer control in developing countries. Environ Health. 2009;10(1):2–2.
    1. Ferlay J, Shin H-R, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008GLOBOCAN 2008. Int J Cancer. 2010;127(12):2893–2917. - PubMed
    1. Piñeros-Petersen M, Pardo-Ramos C, Gamboa-Garay Ó, Hernández-Suárez G. Atlas de mortalidad por cáncer en Colombia. Bogotá: Instituto Nacional de Cancerología - Instituto Geográfico Agustín Codazzi; 2010.
    1. Pardo C, Cendales R. Incidencia estimada y mortalidad por cáncer en Colombia, 2002-2006. Bogotá: Ministerio de la Protección Social - Instituto Nacional de Cancerología; 2010.